FT. LEE, N.J.--(BUSINESS WIRE)--SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.
